 NAPLES, Fla., May 12, 2021 PRNewswire -- Enveric Biosciences NASDAQ: ENVB Enveric or the Company, a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, announced today that it has appointed Arash Asher, M.D. 